Cure My Disease

Don't miss your cure!

 Log in / Sign up

A soothing bath and massage may help clear newborn jaundice faster

NCT ID NCT07771985

Symptom relief Sponsor: Bozok University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 19, 2026 · Last updated Aug 20, 2026 · Updated 1 time

Summary

This trial tests whether a gentle bath under running water, with or without a massage, can help lower bilirubin levels in full-term newborns with jaundice who are receiving phototherapy. Ninety newborns are randomly assigned to one of three groups: bathing, bathing plus massage, or routine care. Bilirubin levels are measured before phototherapy and again at 12 and 24 hours to see if these comforting nursing interventions make a difference.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Underrunning water bathing and underrunning water bathing combined with massage
What this could lead to
If effective, this simple, drug-free nursing care could become a standard comfort measure to help speed up bilirubin reduction in newborns receiving phototherapy.
What could go wrong
This is a small, early-stage study, and results may not apply broadly. The bathing and massage are supportive, not a replacement for phototherapy, and their added benefit needs confirmation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

90 people

The number who actually took part.

Started

Jun 2024

Finished

Mar 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

38 to 42 weeks

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Term newborns with a gestational age between 38 and 42 weeks. * Birth weight of 2500 g or higher. * Newborns diagnosed with physiological hyperbilirubinemia. * Newborns receiving phototherapy treatment. * Postnatal age between 2 and 10 days. * No congenital anomalies. * No additional health problems. * Apgar score ≥7 at the 1st minute after birth. * Stable vital signs. Exclusion Criteria: * Birth weight ≤2500 g. * Gestational age less than 38 weeks. * Pathological jaundice (e.g., ABO incompatibility, Rh incompatibility, biliary atresia, glucose-6-phosphate dehydrogenase deficiency, or glucuronyl transferase enzyme deficiency). * Inability to feed orally. * Postnatal age on the first day of life. * Receiving blood transfusion therapy. * Newborns with secondary conditions such as asphyxia or infection.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Neonatal hyperbilirubinemia are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hyperbilirubinemia Hyperbilirubinemia, Neonatal

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Neonatal hyperbilirubinemia

Contacts and locations

Locations

  • Kayseri City Hospital, Neonatal Intensive Care Unit

    Kayseri, Merkez, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.